Results 71 to 80 of about 10,606 (186)

Comparative Risk of Hepatitis B Virus Reactivation in Patients Receiving Immune Checkpoint Inhibitors or Tyrosine Kinase Inhibitors for Liver Cancer

Alimentary Pharmacology &Therapeutics, Volume 63, Issue 3, Page 383-395, February 2026.
In a cohort of 1596 liver cancer patients with either current or prior HBV infection undergoing systemic therapy in Hong Kong, the risk of HBV reactivation during immune checkpoint inhibitor treatment was low when adequate antiviral prophylaxis was administered, irrespective of HBV infection status.
Dorothy Cheuk‐Yan Yiu, Jimmy Che‐To Lai, Landon Long Chan, Grace Lai‐Hung Wong, Mandy Sze‐Man Lai, Vincent Wai‐Sun Wong, Yee‐Kit Tse, Henry Lik‐Yuen Chan, Stephen Lam Chan, Terry Cheuk‐Fung Yip   +9 more
wiley   +1 more source

Persistence of immunity 18–19 years after vaccination against hepatitis B in 2 cohorts of vaccinees primed as infants or as adolescents in Italy

Human Vaccines & Immunotherapeutics, 2017
This study was aimed at assessing the anti-HBs persistence and immune memory 18–19 y after vaccination against hepatitis B in healthy individuals primed as infants or adolescents.
Luisa Romanò, Cristina Galli, Catia Tagliacarne, Maria Elena Tosti, Claudio Velati, Laura Fomiatti, Maria Chironna, Rosa Cristina Coppola, Mario Cuccia, Rossana Mangione, Fosca Marrone, Francesco Saverio Negrone, Antonino Parlato, Carla Maria Zotti, Alfonso Mele, Alessandro Remo Zanetti, the Study Group   +16 more
doaj   +1 more source

Performance Bounds for Bi-Directional Coded Cooperation Protocols [PDF]

, 2007
In coded bi-directional cooperation, two nodes wish to exchange messages over a shared half-duplex channel with the help of a relay. In this paper, we derive performance bounds for this problem for each of three protocols.
Kim, Sang Joon, Mitran, Patrick, Tarokh, Vahid   +2 more
core   +6 more sources

Identification of prokineticin‐2 as potential pharmacodynamic biomarker for overcoming doxorubicin resistance in multicellular breast cancer spheroids

British Journal of Pharmacology, Volume 183, Issue 3, Page 491-504, February 2026.
Background and purpose Despite advances in immunotherapy, doxorubicin (Dox) chemotherapy is still the irreplaceable first‐line therapy for solid tumours such as breast cancer. However, chemotherapy resistance is the major limiting factor, requiring the use of high doses of Dox to achieve the anti‐tumour actions, often leading to severe side effects ...
Martina Vincenzi, Amin Kremic, Nathalie N. Tscheiller, Po‐Yen Hsu, Michael W. Y. Chan, Roberta Lattanzi, Canan G. Nebigil   +6 more
wiley   +1 more source

Human resources for control of tuberculosis and HIV-associated tuberculosis. [PDF]

, 2005
The global targets for tuberculosis (TB) control were postponed from 2000 to 2005, but on current evidence a further postponement may be necessary.
Bergström, K, Blanc, L, Elzinga, G, Harries, A D, Salaniponi, F, Zachariah, R   +5 more
core   +1 more source

The Role of Viral and Bacterial Infections in the Etiology of Behçet's Disease

Journal of Clinical Laboratory Analysis, Volume 40, Issue 1, January 2026.
Bacterial and viral pathogens may play a key role in Behçet's disease (BD) pathogenesis by triggering autoimmunity, molecular mimicry, or microbiome disruption. These infectious agents could initiate inflammatory pathways, contributing to BD's diverse clinical manifestations.
Mohsen Moghoofei, Hamid Pajavand, Razieh Shahbazi, Marzieh Rezaei, Elahe Taki   +4 more
wiley   +1 more source

Kidney Transplantation From Donors with Hepatitis B [PDF]

, 2016
The growing demand for organ donors to supply the increasing number of patients on kidney waiting lists has led most transplant centers to develop protocols that allow safe use of organs from donors with special clinical situations previously regarded as
Ardita, Vincenzo, Corona, Daniela, Ekser, Burcin, Giaquinta, Alessia, Gozzo, Cecilia, Patanè, Marco, Sinagra, Nunziata, Veroux, Massimiliano, Veroux, Pierfrancesco, Zerbo, Domenico   +9 more
core   +1 more source

Clinical significance of antibody to hepatitis B core antigen in multitransfused hemodialysis patients

Asian Journal of Transfusion Science, 2009
Background: In spite of the progress made in the prevention of transfusion transmitted infections over the last few years, transmission of HBV infection through transfusion of HBsAg negative blood has been documented.
Elghannam Doaa, Aly Rabab, Goda Enas, Eltoraby Ehab, Farag Raghda   +4 more
doaj  

Efficacy of combined HBsAg, anti-HBc and anti-HBs screening in minimizing transfusion transmission risk of hepatitis B infection in low resource setting

Heliyon
Background: Hepatitis B Virus (HBV), and occult Hepatitis B in particular, is a major concern in the transfusion scenario, especially in endemic countries.
Shreyasi Athalye, Amruta Patil, Naveen Khargekar, Shailesh Shinde, Shreya Chavan, Abhay Dixit, Aruna Shankarkumar, Manisha Madkaikar, Anindita Banerjee   +8 more
doaj   +1 more source

PEPFAR Public Health Evaluation -Care and Support -Phase I Uganda [PDF]

, 2009
Phase 1, a survey of 120 care facilities in Kenya and Uganda, found that over 90% of facilities provided some level of clinical, psychological,and preventive care. Pain control was very limited with paracetamol often the only analgesic.
Claire Nsubuga, Eve Namisango, Faith Mwangi-Powell, Geoffrey Banga, Irene J. Higginson, Jacqueline Teera-Ssentoogo, Julia Downing, Richard A. Powell, Richard Harding, Suzanne Penfold, Victoria Simms   +10 more
core